Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for

20.22 - Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis (Rev. 1, 10-03-03) CIM 45-20 The use of EDTA as a chelating agent to treat atherosclerosis, arteriosclerosis, calcinosis, or similar generalized condition not listed by the FDA as an approved use is not covered. Any such use of EDTA is considered experimental. See §20.21 for an explanation of this conclusion.